141 related articles for article (PubMed ID: 19220278)
1. Access to prescribing information for paediatric medicines in the USA: post-modernization.
Young L; Lawes F; Tordoff J; Norris P; Reith D
Br J Clin Pharmacol; 2009 Mar; 67(3):341-6. PubMed ID: 19220278
[TBL] [Abstract][Full Text] [Related]
2. Effect of the pediatric exclusivity provision on children's access to medicines.
Grieve J; Tordoff J; Reith D; Norris P
Br J Clin Pharmacol; 2005 Jun; 59(6):730-5. PubMed ID: 15948940
[TBL] [Abstract][Full Text] [Related]
3. Changes in availability of paediatric medicines in Australia between 1998 and 2002.
Chui J; Tordoff J; Reith D
Br J Clin Pharmacol; 2005 Jun; 59(6):736-42. PubMed ID: 15948941
[TBL] [Abstract][Full Text] [Related]
4. Pediatric licensing status and the availability of suitable formulations for new medical entities approved in the United States between 1998 and 2002.
Balakrishnan K; Grieve J; Tordoff J; Norris P; Reith D
J Clin Pharmacol; 2006 Sep; 46(9):1038-43. PubMed ID: 16920899
[TBL] [Abstract][Full Text] [Related]
5. Establishing a baseline for the monitoring of medicines availability for children in the UK: 1998-2002.
Balakrishnan K; Tordoff J; Norris P; Reith D
Br J Clin Pharmacol; 2007 Jan; 63(1):85-91. PubMed ID: 16869822
[TBL] [Abstract][Full Text] [Related]
6. Access to children's medicines in the United Kingdom, Australia and New Zealand in 1998, 2002 and 2007.
Ragupathy R; Tordoff J; Norris P; Reith D
Pharm World Sci; 2010 Jun; 32(3):386-93. PubMed ID: 20354788
[TBL] [Abstract][Full Text] [Related]
7. Trends in accessibility to medicines for children in New Zealand: 1998-2002.
Chui J; Tordoff J; Kennedy J; Reith D
Br J Clin Pharmacol; 2004 Mar; 57(3):322-7. PubMed ID: 14998428
[TBL] [Abstract][Full Text] [Related]
8. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
Ceci A; Felisi M; Catapano M; Baiardi P; Cipollina L; Ravera S; Bagnulo S; Reggio S; Rondini G
Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
[TBL] [Abstract][Full Text] [Related]
9. A 3-dimensional view of access to licensed and subsidized medicines under single-payer systems in the US, the UK, Australia and New Zealand.
Ragupathy R; Aaltonen K; Tordoff J; Norris P; Reith D
Pharmacoeconomics; 2012 Nov; 30(11):1051-65. PubMed ID: 22963187
[TBL] [Abstract][Full Text] [Related]
10. [Improving drug licensing for children and adolescents : Position paper from the More Medicines for Minors Symposion 8 June 2015 in Bonn].
Riedel C; Lehmann B; Broich K; Sudhop T
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Dec; 59(12):1587-1592. PubMed ID: 27778087
[TBL] [Abstract][Full Text] [Related]
11. Dosing information for paediatric patients: are they really "therapeutic orphans"?
Tan E; Cranswick NE; Rayner CR; Chapman CB
Med J Aust; 2003 Aug; 179(4):195-8. PubMed ID: 12914509
[TBL] [Abstract][Full Text] [Related]
12. [Medicines for children and "off-label use" 5 years after implementation of the Paediatric Regulation (EC) No 1901/2006. An interim analyis].
Afentaki A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Sep; 57(9):1111-9. PubMed ID: 25139386
[TBL] [Abstract][Full Text] [Related]
13. Extemporaneous (magistral) preparation of oral medicines for children in European hospitals.
Brion F; Nunn AJ; Rieutord A
Acta Paediatr; 2003 Apr; 92(4):486-90. PubMed ID: 12801118
[TBL] [Abstract][Full Text] [Related]
14. Extemporaneous (magistral) preparation of oral medicines for children in European hospitals.
Conroy S
Acta Paediatr; 2003 Apr; 92(4):408-10. PubMed ID: 12801103
[TBL] [Abstract][Full Text] [Related]
15. The European paediatric legislation: benefits and perspectives.
Rocchi F; Paolucci P; Ceci A; Rossi P
Ital J Pediatr; 2010 Aug; 36():56. PubMed ID: 20716337
[TBL] [Abstract][Full Text] [Related]
16. Incorrect overdose management advice in the Physicians' Desk Reference.
Mullen WH; Anderson IB; Kim SY; Blanc PD; Olson KR
Ann Emerg Med; 1997 Feb; 29(2):255-61. PubMed ID: 9018192
[TBL] [Abstract][Full Text] [Related]
17. Off-label prescribing to children in primary care: retrospective observational study.
Ekins-Daukes S; Helms PJ; Simpson CR; Taylor MW; McLay JS
Eur J Clin Pharmacol; 2004 Jul; 60(5):349-53. PubMed ID: 15146302
[TBL] [Abstract][Full Text] [Related]
18. Determinants for drug prescribing to children below the minimum licensed age.
't Jong GW; Eland IA; Sturkenboom MC; van den Anker JN; Stricker BH
Eur J Clin Pharmacol; 2003 Feb; 58(10):701-5. PubMed ID: 12610748
[TBL] [Abstract][Full Text] [Related]
19. Unlicensed and off label drug use in acute lymphoblastic leukaemia and other malignancies in children.
Conroy S; Newman C; Gudka S
Ann Oncol; 2003 Jan; 14(1):42-7. PubMed ID: 12488291
[TBL] [Abstract][Full Text] [Related]
20. Drug prescribing pattern for under-fives in a paediatric clinic in South-Western Nigeria.
Fadare J; Olatunya O; Oluwayemi O; Ogundare O
Ethiop J Health Sci; 2015 Jan; 25(1):73-8. PubMed ID: 25733787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
